BioMachines Launches Proteomics Division

BioMachines Inc. has launched a new services division: Applied Proteomics Services. The group provides diverse proteomic sample preparation, fractionation and mass spectrometry services for state-of-the-art analysis. Applied Proteomics Services will utilize its fully integrated technology platform to provide real advantages in data quality, throughput and the ability to review, interpret and troubleshoot experimental outcomes.

The new division arises from an agreement with the University of Massachusetts Medical School’s Proteomic Fractionation Group (PFG); BioMachines will leverage the experience of UMMS researchers Sunny Tam, Ph.D. and Douglas Hinerfeld, Ph.D. to support the Applied Proteomics Services group.

“This new relationship combines the deep knowledge and expertise of the PFG team with proven sample preparation automation equipment, to offer our customers the best combined set of resources on the market,” said Tom Larrichio, BioMachines’ chief executive officer. “Protein-based biopharmaceuticals are enjoying great commercial success. Specifically, monoclonal antibodies are a very exciting area, where sales are projected to grow from a $15 billion market in 2005 to a $27 billion market in 2010. This is in addition to protein analysis that is required for small-molecule therapies. We are focused on this growing market by providing expertise in protein analysis through a fee-for-services model.”